COVID-19 and fungal infection: the need for a strategic approach
- PMID: 33521720
- PMCID: PMC7832937
- DOI: 10.1016/S2666-5247(20)30127-0
COVID-19 and fungal infection: the need for a strategic approach
Comment on
-
COVID-19 and fungal superinfection.Lancet Microbe. 2020 Jul;1(3):e107. doi: 10.1016/S2666-5247(20)30065-3. Epub 2020 Jul 3. Lancet Microbe. 2020. PMID: 32835341 Free PMC article. No abstract available.
References
-
- Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis. 2005;40:1762–1769. - PubMed
-
- White PL, Dhillon R, Cordey A. A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU. SSRN. 2020 https://papers.ssrn.com/abstract=3644400 published online July 14. (preprint) - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical